Bharat Parenterals Limited (BOM:541096)

Bharat Parenterals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-81.88	-126.26	145.17	157.15	213.04
Depreciation & Amortization	342.51	353.22	90.21	58.82	66.61
Loss (Gain) From Sale of Assets	-1.61	9.76	0.85	0.91	7.4
Loss (Gain) From Sale of Investments	-0.7	2.83	-	-3.42	-11.25
Stock-Based Compensation	-	-	1.4	5.31	-4.01
Provision & Write-off of Bad Debts	12.73	7.89	-	-	-
Other Operating Activities	-95.79	-288.04	-31.76	10	2.06
Change in Accounts Receivable	174.65	-251.55	-279.94	-391.58	-51.01
Change in Inventory	-127.64	-104.84	-236.26	-170.82	16.72
Change in Accounts Payable	-102.15	146.87	86.28	346.39	-36.22
Change in Other Net Operating Assets	263.51	-22.41	136.97	197.04	-424.09
Operating Cash Flow	383.62	-272.54	-47.06	216.64	-220.75
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-399.33	-290.76	-1,043	-916.01	-47.63
Sale of Property, Plant & Equipment	2.73	4.55	7.01	15.09	0.8
Cash Acquisitions	-	-543.88	-	-	-
Investment in Securities	-10.93	-52.67	-	118.24	266.42
Other Investing Activities	500.74	-491.09	-11.83	4.48	-2
Investing Cash Flow	93.21	-1,374	-1,048	-778.19	217.59

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	199.14	455.94	332.43	15.86
Long-Term Debt Issued	459.75	27.05	622.42	-	36.5
Total Debt Issued	459.75	226.19	1,078	332.43	52.36
Short-Term Debt Repaid	-800.06	-	-	-	-
Long-Term Debt Repaid	-	-	-	-12.44	-24.71
Total Debt Repaid	-800.06	-	-	-12.44	-24.71
Net Debt Issued (Repaid)	-340.31	226.19	1,078	319.99	27.65
Issuance of Common Stock	-	1,473	4.46	-	4.46
Common Dividends Paid	-6.88	-5.82	-4.33	-	-
Other Financing Activities	-123.28	-129.5	25.8	285.99	-9.67
Financing Cash Flow	-470.46	1,564	1,104	605.98	22.43

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	0	-0	0	-
Net Cash Flow	6.37	-82.67	9.38	44.42	19.27

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-15.71	-563.3	-1,090	-699.37	-268.38
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-0.46%	-16.55%	-41.73%	-31.89%	-12.64%
Free Cash Flow Per Share	-3.88	-85.95	-187.24	-121.11	-46.75
Levered Free Cash Flow	111.38	-1,096	-987	-959.81	83.02
Unlevered Free Cash Flow	189.73	-1,021	-967.12	-946.15	89.07

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	123.28	129.5	32.25	21.86	9.67
Cash Income Tax Paid	99.36	105.95	94.63	87.92	56.7
Change in Working Capital	208.37	-231.94	-292.94	-18.97	-494.6

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error